All Stories

  1. Re‐parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search
  2. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
  3. A Scoping Review of West Nile Virus Seroprevalence Studies among African Equids
  4. Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study
  5. Retrospective serological survey for influenza in horses from Brazil
  6. Systematic review and meta‐analysis of seroprevalence studies of West Nile virus in equids in Europe between 2001 and 2018
  7. Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
  8. Serosurvey of pandemic H1N1 influenza A virus in dogs in Andalusia (southern Spain)
  9. Equine viral encephalitis: prevalence, impact, and management strategies
  10. Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice
  11. The challenges posed by equine arboviruses
  12. Strategic implementation of vaccines for control of equine influenza
  13. The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
  14. The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?
  15. Canine parvovirus study
  16. Making sense of altmetrics
  17. Controlling equine influenza: Traditional to next generation serological assays
  18. Small animal disease surveillance: respiratory disease
  19. Modulation of Potassium Channels Inhibits Bunyavirus Infection
  20. Technical considerations for the generation of novel pseudotyped viruses
  21. Diversity of group A rotavirus on a UK pig farm
  22. Seroprevalence of Schmallenberg virus in the United Kingdom and the Republic of Ireland: 2011–2013
  23. In memoriam – Richard M. Elliott (1954–2015)
  24. Comparison of Schmallenberg virus antibody levels detected in milk and serum from individual cows
  25. Identification of morphological differences between avian influenza A viruses grown in chicken and duck cells
  26. High Basal Expression of Interferon-Stimulated Genes in Human Bronchial Epithelial (BEAS-2B) Cells Contributes to Influenza A Virus Resistance
  27. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010–2012
  28. Pseudotypes: your flexible friends
  29. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy
  30. The genetics of virus particle shape in equine influenza A virus
  31. Wildlife Vectors of Schmallenberg?
  32. What can mathematical models bring to the control of equine influenza?
  33. Current progress with serological assays for exotic emerging/re-emerging viruses
  34. SBV transmission
  35. Evolution of Equine Influenza Virus in Vaccinated Horses
  36. Testing for Schmallenberg Virus
  37. Schmallenberg virus
  38. Neuraminidase inhibitors for treatment of equine influenza – when all else fails?
  39. Recombination and positive selection identified in complete genome sequences of Japanese encephalitis virus
  40. herpesviruses in Egyptian rodents
  41. Antigenic and Genetic Evolution of Equine Influenza A (H3N8) Virus from 1968 to 2007
  42. Equine influenza: A review of an unpredictable virus
  43. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples
  44. Intra- and Interhost Evolutionary Dynamics of Equine Influenza Virus
  45. Dynamics of Influenza Virus Infection and Pathology
  46. Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza
  47. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007
  48. Control of equine influenza: scenario testing using a realistic metapopulation model of spread
  49. Vaccine failure caused an outbreak of equine influenza in Croatia
  50. Transmission of Equine Influenza Virus to English Foxhounds
  51. Protection, systemic IFNγ, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host
  52. Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003
  53. New assays to measure equine influenza virus-specific Type 1 immunity in horses
  54. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short‐term vaccine efficacy study
  55. Frequency and phenotype of EHV-1 specific, IFN-γ synthesising lymphocytes in ponies: The effects of age, pregnancy and infection
  56. Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
  57. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
  58. Vaccination against equine influenza: Quid novi?
  59. Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection
  60. Investigation of Equine Influenza Cases Exhibiting Neurological Disease: Coincidence or Association?
  61. Evaluation of the Binax NOW Flu A test kit for the rapid detection of equine influenza virus
  62. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease
  63. Equine influenza in dogs: Too late to bolt the stable door?
  64. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses
  65. Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population
  66. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1
  67. Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): Evidence for frozen evolution
  68. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an ‘American lineage’ H3N8 virus
  69. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines
  70. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population
  71. Current perspectives on control of equine influenza
  72. Unifying the Epidemiological and Evolutionary Dynamics of Pathogens
  73. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines
  74. Optimising vaccination strategies in equine influenza
  75. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred
  76. Influenza HA DNA induces Th1 cells and protection despite limited antibody responses
  77. Methods for determining resistance to neuraminidase inhibitors
  78. Viral Infections of the Equine Respiratory Tract
  79. Correspondence
  80. Antigenic and genetic evolution of equine H3N8 influenza A viruses
  81. Genetic and Antigenic Analysis of the Influenza Virus Responsible for the 1992 Hong Kong Equine Influenza Epizootic
  82. Genetic and antigenic analysis of an equine influenza H 3 isolate from the 1989 epidemic